Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2007

Conditions
Sinus Implant Reconstruction
Interventions
DEVICE

Macroporous Biphasic Calcium Phosphate-Fibrin Sealant Vapor Heated Solvent/Detergent Treated 4 IU/ML Thrombin (MBCP-FS)

Trial Locations (3)

24105

Universitätsklinikum Schleswig Holstein, Campus Kiel, Kiel

91054

Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie der Universität Erlangen-Nürnberg, Erlangen

99089

Klinik für Mund-, Kiefer- und Gesichtschirurgie des Helios-Klinikums Erfurt, Erfurt

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT00163605 - Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures | Biotech Hunter | Biotech Hunter